Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

@article{Lieberman2005EffectivenessOA,
  title={Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.},
  author={Jeffrey A. Lieberman and T. Scott Stroup and J. P. Mcevoy and Marvin S. Swartz and Robert A. Rosenheck and Diana O. Perkins and Richard S. E. Keefe and Sonia M. Davis and Clarence E. Davis and Barry Lebowitz and Joanne B. Severe and John K. Hsiao},
  journal={The New England journal of medicine},
  year={2005},
  volume={353 12},
  pages={
          1209-23
        }
}
BACKGROUND The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. We compared a first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study. METHODS A total of 1493 patients with schizophrenia were recruited at 57 U.S. sites and randomly assigned to receive olanzapine (7.5 to 30 mg per day), perphenazine (8… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 2,168 CITATIONS, ESTIMATED 48% COVERAGE

Update on typical and atypical antipsychotic drugs.

  • Annual review of medicine
  • 2013
VIEW 19 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics

  • Journal of psychopharmacology
  • 2011
VIEW 9 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2020

CITATION STATISTICS

  • 202 Highly Influenced Citations

  • Averaged 117 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES